Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 251Neoplasms 219Carcinoma, Non-Small-Cell Lung 201Colorectal Neoplasms 151Prostatic Neoplasms 141Lung Neoplasms 117Neoplasm Metastasis 109Ovarian Neoplasms 100Multiple Myeloma 95Pancreatic Neoplasms 83Leukemia, Myeloid, Acute 81Squamous Cell Carcinoma of Head and Neck 71Melanoma 63Endometrial Neoplasms 63Stomach Neoplasms 62Glioblastoma 56Recurrence 54Carcinoma, Hepatocellular 53Urinary Bladder Neoplasms 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Lymphoma 50Brain Neoplasms 50Carcinoma, Renal Cell 49Triple Negative Breast Neoplasms 46Hematologic Neoplasms 46Head and Neck Neoplasms 46Esophageal Neoplasms 45Sarcoma 43Glioma 43Colonic Neoplasms 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Large B-cell Lymphoma × 30 days × Clear all
NCT07215585 2026-05-22

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting
420 enrolled
Lymphoid

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡